CpG Island Methylation in Colorectal Cancer: Past, Present and Future
2011
CpG Island Methylation in Colorectal Cancer
publication
Evidence: high
Author Information
Author(s): Karen Curtin, Martha L. Slattery, Wade S. Samowitz
Primary Institution: University of Utah Health Sciences Center
Hypothesis
What is the role of CpG island methylation in colorectal cancer?
Conclusion
The study highlights the significance of CpG island methylation in colorectal cancer biology and its potential for future diagnostics and treatments.
Supporting Evidence
- CIMP is significantly more frequent in tumors of the proximal colon compared to distal colon and rectal cancers.
- Most sporadic microsatellite unstable colon tumors are CIMP positive.
- CIMP is associated with BRAF mutations in both microsatellite stable and unstable colon cancers.
- Hyperplastic polyps are now considered to represent a heterogeneous group, many of which exhibit CIMP.
Takeaway
This study looks at how certain changes in DNA can affect cancer in the colon, helping scientists understand how to better diagnose and treat it.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website